• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应对中国和巴西血友病护理和患者支持的挑战。

Meeting the challenges of haemophilia care and patient support in China and Brazil.

机构信息

Unidade de Hemofilia 'Cláudio Luis Pizzigatti Corrêa', INCT do Sangue Hemocentro UNICAMP, University of Campinas, Campinas, São Paulo, Brazil.

出版信息

Haemophilia. 2012 Jul;18 Suppl 5:33-8. doi: 10.1111/j.1365-2516.2012.02890.x.

DOI:10.1111/j.1365-2516.2012.02890.x
PMID:22757682
Abstract

Projects are underway in many developing countries to try to improve the provision of treatment and access to care for people with haemophilia (PWH), as long-term prophylactic treatment, which improves quality of life for PWH, is still restricted to developed countries. In most developing countries, therapy is limited to on-demand treatment or even no replacement treatment at all. Combined with limited healthcare resources, this lack of treatment can lead to a vicious circle of lack of care, disability, unemployment and lack of access to health insurance for haemophilia patients. In China, the establishment of the Haemophilia Treatment Centre Collaborative Network of China (HTCCNC), in conjunction with the World Federation of Hemophilia, has improved haemophilia care and the identification of PWH. In Brazil, on-demand treatment has improved the health of PWH but does not prevent musculoskeletal (MSK) complications, the major cause of deterioration in quality of life for PWH. The Novo Nordisk Haemophilia Foundation BR2 project was therefore designed to improve quality of life of PWH through improvements in their physical, mental and social wellbeing. This paper will briefly review these projects and describe the current status of haemophilia care in these countries. While there is still a long way to go before optimal care becomes a reality for all PWH in developing countries, significant progress has been made, and knowledge of the impact and outcomes of these projects can inform best practice worldwide.

摘要

许多发展中国家正在开展项目,试图改善为血友病患者(PWH)提供的治疗和护理服务,因为长期预防性治疗可以提高 PWH 的生活质量,但这种治疗仍仅限于发达国家。在大多数发展中国家,治疗仅限于按需治疗,甚至根本没有替代治疗。再加上医疗保健资源有限,这种缺乏治疗可能会导致缺乏护理、残疾、失业以及血友病患者无法获得医疗保险的恶性循环。在中国,血友病治疗中心协作网络(HTCCNC)的建立,与世界血友病联合会合作,改善了血友病的护理和 PWH 的识别。在巴西,按需治疗改善了 PWH 的健康状况,但不能预防肌肉骨骼(MSK)并发症,这是 PWH 生活质量恶化的主要原因。因此,诺和诺德血友病基金会 BR2 项目旨在通过改善 PWH 的身体、心理和社会福利来提高他们的生活质量。本文将简要回顾这些项目,并描述这些国家目前的血友病护理状况。虽然在发展中国家为所有 PWH 实现最佳护理还有很长的路要走,但已经取得了重大进展,了解这些项目的影响和结果可以为全球提供最佳实践。

相似文献

1
Meeting the challenges of haemophilia care and patient support in China and Brazil.应对中国和巴西血友病护理和患者支持的挑战。
Haemophilia. 2012 Jul;18 Suppl 5:33-8. doi: 10.1111/j.1365-2516.2012.02890.x.
2
National haemophilia programme development in the Republic of Georgia.格鲁吉亚共和国的国家血友病项目发展
Haemophilia. 2005 Sep;11(5):529-34. doi: 10.1111/j.1365-2516.2005.01127.x.
3
Differences between developed and developing countries in paediatric care in haemophilia.发达国家与发展中国家在儿童血友病治疗方面的差异。
Haemophilia. 2012 Jul;18 Suppl 4:94-100. doi: 10.1111/j.1365-2516.2012.02875.x.
4
Haemophilia care in India: innovations and integrations by various chapters of Haemophilia Federation of India (HFI).印度的血友病护理:印度血友病联合会(HFI)各分会的创新与整合。
Haemophilia. 2010 Jan;16(1):61-5. doi: 10.1111/j.1365-2516.2009.02097.x. Epub 2009 Sep 23.
5
Haemophilia care in China: achievements of a decade of World Federation of Hemophilia treatment centre twinning activities.中国的血友病护理:世界血友病联盟治疗中心结对活动十年成果
Haemophilia. 2008 Sep;14(5):879-88. doi: 10.1111/j.1365-2516.2008.01821.x. Epub 2008 Jul 15.
6
Establishing a harmonized haemophilia registry for countries with developing health care systems.为医疗体系尚不完善的国家建立协调一致的血友病登记处。
Haemophilia. 2013 Sep;19(5):668-73. doi: 10.1111/hae.12147. Epub 2013 Apr 17.
7
Haemophilia Experiences, Results and Opportunities (HERO study) in Brazil: Assessment of the psychosocial effects of haemophilia in patients and caregivers.巴西血友病患者经历、结果和机遇(HERO 研究):评估血友病患者及其照顾者的心理社会影响。
Haemophilia. 2019 Jul;25(4):640-650. doi: 10.1111/hae.13774. Epub 2019 May 21.
8
The demographics, treatment characteristics and quality of life of adult people with haemophilia in China - results from the HERO study.中国成年血友病患者的人口统计学特征、治疗特点及生活质量——HERO研究结果
Haemophilia. 2017 Jan;23(1):89-97. doi: 10.1111/hae.13071. Epub 2016 Sep 6.
9
Common themes and challenges in hemophilia care: a multinational perspective.血友病护理中的常见主题与挑战:跨国视角
Hematology. 2019 Dec;24(1):39-48. doi: 10.1080/10245332.2018.1505225. Epub 2018 Aug 3.
10
Musculoskeletal problems in persons with inhibitors: how do we treat?抑制物患者的肌肉骨骼问题:我们如何治疗?
Haemophilia. 2012 Jul;18 Suppl 4:54-60. doi: 10.1111/j.1365-2516.2012.02874.x.

引用本文的文献

1
Retrospective analysis of clinical data from 171 low-income patients with hemophilia in Shandong Province.山东省171例低收入血友病患者临床资料的回顾性分析。
Sci Rep. 2025 Feb 18;15(1):5867. doi: 10.1038/s41598-025-90436-y.
2
Analysis of hospitalization of people with hemophilia-12 years of experience in a single center.血友病患者住院情况分析——单中心12年经验
Res Pract Thromb Haemost. 2022 Jul 21;6(5):e12764. doi: 10.1002/rth2.12764. eCollection 2022 Jul.
3
Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China.
中国重度 A 型血友病成人患者药物代谢动力学指导预防与标准预防的成本效果分析。
Adv Ther. 2022 Aug;39(8):3777-3788. doi: 10.1007/s12325-022-02220-3. Epub 2022 Jun 30.
4
Platelet immunology of patients with hemophilia.血友病患者的血小板免疫学
Am J Transl Res. 2021 Aug 15;13(8):9831-9838. eCollection 2021.
5
The existing scenario of haemophilia care in Canada and China - A review.加拿大和中国血友病护理的现状——综述
Hematol Transfus Cell Ther. 2020 Oct-Dec;42(4):356-364. doi: 10.1016/j.htct.2019.08.001. Epub 2019 Oct 27.
6
Efficacy and safety of prophylaxis with BAY 81-8973 in Chinese patients with severe haemophilia A enrolled in the LEOPOLD II trial.在 LEOPOLD II 试验中接受 BAY 81-8973 预防治疗的中国重度 A 型血友病患者的疗效和安全性。
Haemophilia. 2019 May;25(3):e153-e158. doi: 10.1111/hae.13751. Epub 2019 Apr 17.
7
[Breakthrough bleeding in adult patients with severe hemophilia A receiving low- and intermediate-dose FVIII for tertiary prophylaxis: characteristics and influencing factors].[接受低剂量和中等剂量FVIII进行三级预防的重度A型血友病成年患者的突破性出血:特征及影响因素]
Nan Fang Yi Ke Da Xue Xue Bao. 2017 Oct 20;37(10):1391-1395. doi: 10.3969/j.issn.1673-4254.2017.10.18.
8
Retrospective analysis of 1,226 Chinese patients with haemophilia in a single medical centre.对一家医疗中心的1226例中国血友病患者进行回顾性分析。
J Thromb Thrombolysis. 2014 Jul;38(1):92-7. doi: 10.1007/s11239-013-1009-6.